I think this is the issue with profitability of this tech. EIQ will get FDA approval based on this, but I wonder if the big medical device manufacturers will just bundle their own AI with their devices, making it less likely to command a premium price for a third party provider like EIQ. The device manufacturers will also have massive databases of echocardiograms.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.003(1.05%) |
Mkt cap ! $151.6M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 23.5¢ | $149.4K | 630.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 215535 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 176162 | 2 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |